The U.S. Food and Drug Administration recently took a small step towards providing industry with the long-awaited guidance on how pharmaceutical maker
Continue Reading FDA Issues Draft Guidance on Social Media
Mass Tort Defense
Defense of Mass Tort Claims, Class Actions, and Significant Product-Based Litigation